AltheaDx
Latest round
- Series C
Last raised
- Dec 2015
Total raised
- $36M
Investors
- 5
About AltheaDx
AltheaDx Inc.Founded in 2013, AltheaDx Inc. is based in San Diego, US, and specializes in diagnostic solutions for skin cancers. The company was acquired by Castle Biosciences Incorporated in a transaction valued at USD 65 mn, completed on April 26, 2022. The founders include François Ferré and Magda Marquet, and the current CEO is David Nikodem.AltheaDx Inc. offers a range of advanced diagnostic tests aimed at improving the management and treatment of skin cancers, including the DecisionDx-Melanoma and DecisionDx-SCC tests, which assess the metastatic risk and predict recurrence in melanoma and squamous cell carcinoma patients, respectively. It also provides TissueCypher for Barrett's Esophagus and MyPath Melanoma, enhancing diagnostic accuracy for these conditions.58 mn.Looking forward, AltheaDx plans to leverage its recent acquisition to enhance its product offerings and expand into new global markets. AltheaDx is targeting rapid growth in international markets, particularly in Europe and Asia, by the end of 2023, capitalizing on the increasing demand for personalized medicine in oncology.
Who invested in AltheaDx
5 investors across 2 rounds
See all investors in AltheaDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AltheaDx
Who invested in AltheaDx?
AltheaDx has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AltheaDx raised?
AltheaDx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AltheaDx last raise money?
AltheaDx's most recent round on record is a Series C, in Dec 2015.
What does AltheaDx do?
AltheaDx is a biotechnology company.
Where is AltheaDx headquartered?
AltheaDx is headquartered in San Diego, US.
Which VCs invest in companies like AltheaDx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AltheaDx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like AltheaDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.